Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CCDC85A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SMIM20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BHLHB9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPIRE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XAGE3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01343 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
FHL5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEFF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC46A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC6A11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP35 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORD65 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKMY1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC390705 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACSF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on